Compare QNRX & GGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNRX | GGRP |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 12.5M |
| IPO Year | 2023 | 2021 |
| Metric | QNRX | GGRP |
|---|---|---|
| Price | $8.69 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.4K | ★ 123.1K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.54 |
| 52 Week High | $41.80 | $0.61 |
| Indicator | QNRX | GGRP |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 50.89 |
| Support Level | $8.03 | $0.54 |
| Resistance Level | $10.05 | $0.61 |
| Average True Range (ATR) | 0.80 | 0.05 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 47.73 | 85.36 |
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.